Company Overview

Development Stage

About the Company

Company Name: Guangzhou Baiyunshan Pangaoshou Pharmaceutical Co., Ltd.
Industry: Pharmaceutical Manufacturing
Company Nature: State-owned Holding
Company Profile: Guangzhou Pharmaceutical Holdings Limited is a wholly state-owned company authorized by the Guangzhou Municipal Government to manage state-owned assets. It is mainly engaged in the R&D and manufacturing of Chinese patent medicines and botanical drugs, chemical APIs and preparations, biological drugs, and big health products, as well as trading, logistics and distribution, and medical and health services. It is a large enterprise group integrating science, industry, and trade, which is a key support and development target of Guangzhou City. GPG has one listed company, "Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd." (listed on the Hong Kong H-share and Shanghai A-share markets), and nearly 30 member enterprises. In 2014, GPG achieved industrial and commercial sales revenue of nearly 65 billion RMB, a year-on-year growth of over 18%, ranking 201st among China's Top 500 Enterprises in 2015, and has been ranked first in the "Top 100 Chinese Pharmaceutical Industry" list for four consecutive years. GPG has also been rated as "China's Top Ten Most Achieved Enterprises", "National Model Unit for Corporate Culture Construction in the Pharmaceutical Industry", "Outstanding Enterprise Promoting Guangdong Economic Development in 2013", "Guangdong Province Independent Innovation Benchmark Enterprise", "Guangdong Province Demonstration Enterprise for Transformation and Upgrading of Advantageous Traditional Industries", and "Outstanding Enterprise in Guangdong Pharmaceutical Industry". GPG has formulated a clear roadmap to realize its "Guangzhou Pharmaceutical Dream": by 2017, to enter the "100 Billion Club" and become a "hundred-billion-level" large enterprise aircraft carrier; by 2020, to reach a new peak of 150 billion RMB and enter the Fortune Global 500; and by 2025, to achieve the strategic goal of ranking among the top 20 in the global pharmaceutical and health industry. Guangzhou Baiyunshan Pangaoshou Pharmaceutical is a key enterprise under GPG. The company was founded in the 16th year of Guangxu Emperor of the Qing Dynasty (AD 1890), with a history of 130 years, and is renowned for producing Chinese patent medicines for relieving cough and resolving phlegm. The company is located in Dongsheng Industrial Zone, Panyu District, Guangzhou City, covering an area of 50,000 square meters, with a building area of 80,000 square meters. The company not only has modern GMP-compliant factories and world-class automatic production lines imported from abroad, but also has established a comprehensive quality assurance system. The company currently produces various dosage forms such as decoctions, oral solutions, capsules, syrups, and mixtures, including more than 40 famous and high-quality products for respiratory system, gynecology, pediatrics, and tumor adjuvants. Among them, the nationally best-selling Zhike Chuanbei Pipa Dew, Shede Chuanbei Liquid, Shede Chuanbei Pipa Paste, Milian Chuanbei Pipa Paste, and Danbi Capsules are the company's four pillar products, deeply trusted and favored by consumers. Pangaoshou Pharmaceutical owns two national intangible cultural heritages: "Pangaoshou Traditional Chinese Medicine Culture" and "Pangaoshou Herbal Tea Prescriptions and Professional Terminology", making it one of the few enterprises in China's pharmaceutical industry with "dual national heritage" status. In addition, "Pangaoshou" has also won the titles of "National Well-known Trademark" and "China Time-honored Brand". Adhering to the philosophy of "A century of cough treatment, with genuine materials", the company will continue to strengthen its professional field of cough-relieving Chinese patent medicines, strive to build a leading brand in respiratory system Chinese patent medicines, enhance core competitiveness through technological innovation, management innovation, marketing innovation, and brand innovation, and benefit humanity with the brand image of "Health, Happiness, and Longevity". We welcome outstanding 2021 graduates with excellent academic performance, practical work attitude, good character and scholarship, outgoing personality, lively and approachable, with rich social practice experience, especially those with experience as student cadres or club cadres, to actively apply.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

How Fast Is Hiring Growing? (31 open positions)

Manage
Note: How fast is hiring at Guangzhou Baiyunshan Pangaoshou Pharmaceutical Co., Ltd. growing? 2026: 36 openings (down 25%), 2025: 48 openings (flat), 2024: 48 openings (up 23%), 2023: 39 openings (up 105%), 2022: 19 openings (down 83%), 2021: 113 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Master's Degree Job Demand Analysis

(More)
+50%
Growth Rate
2026 vs 2025
Master's Hiring by Year: 2026 — 1 more jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Guangzhou Baiyunshan Pangaoshou Pharmaceutical Co., Ltd. growing? Master's recruitment over the years: 2026: 3 openings (down 25%), 2025: 2 openings (flat), 2022: 1 openings (down 83%), 2021: 1 openings.

— What Are the Salaries Like? (44 records)

Manage
salary range: 8K - 30K, 97.8% of roles pay ¥10-30K
Note: salary statistics are based on 44 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Guangzhou Baiyunshan Pangaoshou Pharmaceutical Co., Ltd.?97.8% of positions earn 10-30K, Undergraduate salary: ¥。销售类 average salary ¥20.8K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of

(More)
Are salaries high at Guangzhou Baiyunshan Pangaoshou Pharmaceutical Co., Ltd.? We provide: 渠道,大区经理,销售,地区经理,研究专员,管培生,qc,检验,设备管理,质量,临床,产品经理,学术经理,审计,销管,系统开发,药学. Click to view detailed salary analysis by job.

Related Industry Tags

Job Category

  • 销售类
    54.5% of total 54.5%
  • 商业零售类
    27.3% of total 27.3%
  • 其他(研发和技术类)
    13.6% of total 13.6%
  • 医疗卫生/美容保健类
    9.1% of total 9.1%

Education

  • 本科
    77.3% of total 77.3%
  • 大专
    11.4% of total 11.4%
  • 硕士
    11.4% of total 11.4%

Experience

  • 不限
    88.6% of total 88.6%
  • 1-3年
    11.4% of total 11.4%
View Detailed Analysis

What does Guangzhou Baiyunshan Pangaoshou Pharmaceutical Co., Ltd. require? Who is Guangzhou Baiyunshan Pangaoshou Pharmaceutical Co., Ltd. hiring? recruitment: 销售类占比最多占54.5%,其次是商业零售类占27.3%. What education can get in at ? 本科占比最多占77.3%,其次是大专占11.4%. High education required at ? 硕士占11.4%. Work experience required at ? 不限占比最多占88.6%,其次是1-3年占11.4%. Where are the job locations at ? 广州占比最多占61.4%,其次是天津占4.5%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 6,544万(元)
Legal Representative: 林辉
Date Established:
Credit Code: 91440101190487808H
Registered Address: 广州市番禺区东环街天保路11号

Partners & Suppliers

广东瑞源科技股份有限公司向其采购中成药产品,为公司主要供应商之一。 Source
合作客户 医药制造(中成药)
至信药业为其提供中药饮片 Source
供应商 中药制药企业
合作进行止咳化痰类中药药效评价 Source
供应商 医药研发服务(内部客户)
采购潘高寿的止咳化痰类中成药,如川贝枇杷露、蛇胆川贝液等。 Source
合作客户 药品生产/供应
广州医药作为广药集团旗下分销平台,负责潘高寿产品的批发与配送。 Source
合作客户 医药分销/批发

People who follow this company also follow

Competitors (Similar Companies)

制药/药业 医药 抗体 科学研究
“A pharmaceutical group committed to the research, development, product”
“Research, development, and production of anti-tumor and surgical medic”
制药/药业 生物制品 抗生素 中成药
制药/药业 医药 维生素 葡萄糖
“Products for the diagnosis and treatment of allergic diseases”
卫生材料 药物研发 生物制药 新药研发
生物科技/生物工程 麦芽糖 淀粉糖 山梨糖醇
医药 制药/药业 原料药 健康科技
医药 创新药 药物研发 产业园区开发
制药/药业 医药 生物制药 神经系统疾病药物
食品 饮料 凉茶 营养食品
“Dedicated to the research, development, production, and commercializat”
“Rapid test product R&D and manufacturer”
制药/药业 医药 中药现代化 药材种植

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates